Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07543497
Performance and Impact of the Sepsis ImmunoScore
Sponsor: Prenosis, Inc.
View on ClinicalTrials.gov
Summary
The goal of this prospective cohort device study is to assess clinical usage and impact, diagnostic performance, and prognostic performance of the Sepsis ImmunoScore.
Official title: Clinical Utility and Performance of the Sepsis ImmunoScore: A Prospective Cohort Device Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
5000
Start Date
2026-04
Completion Date
2027-12
Last Updated
2026-04-22
Healthy Volunteers
No
Conditions
Interventions
DIAGNOSTIC_TEST
Sepsis ImmunoScore
The Sepsis ImmunoScore is a risk stratification tool that uses Artificial Intelligence/Machine Learning to aid in the identification of patients likely to have or progress to sepsis within 24 hours of assessment.